Antares Vision S p A : PR - Procedures and Exercise Ratio - 4 october 2021.
10/04/2021 | 01:27pm EST
PROCEDURES AND EXERCISE RATIO OF ANTARES VISION WARRANTS
Travagliato (BS), 4 October 2021 - Antares Vision S.p.A. ("Antares Vision" or the "Company") announces that, pursuant to article 3 of the Regulation of "Antares Vision S.p.A. Warrants" (respectively, the "Warrants Regulation"1 and the "Warrants"), the Average Monthly Price for September 2021 is Euro 12.1019 (source FactSet, Average Monthly Price calculated as the arithmetic average of the official prices of ordinary Antares Vision S.p.A. shares on stock market trading days in September).
Therefore, as the Strike Price is Euro 9.50 and the Subscription Price of the Conversion Shares is Euro 0.10, the Exercise Ratio for October 2021 is 0.2167.
Any request to exercise the Warrants must be submitted to the broker who is a member of the centralised management system of Monte Titoli S.p.A., where the Warrants are deposited, by the Last Trading Day of October 2021. The Company will make the relative Conversion Shares available for trading, through Monte Titoli S.p.A., on the settlement day following the end of October 2021. The conversion shares will have the same dividends as ordinary shares on the effective date of exercise of the Warrants.
The Subscription Price must be fully paid into the Company's current account indicated below at the time the exercise request is submitted:
IT 59 V 05387 11236 000042573777
In all cases in which at the time the Warrants are exercised, a fractional number of Conversion Shares is due, the Warrant holder will have the right to receive Conversion Shares up to the amount of the immediately lower whole number and will not have any right with regard to the fractional part in excess.
At the time the exercise request is submitted, the Warrant holder shall acknowledge that the Conversion Shares assigned under exercise of the Warrants have not been registered pursuant to the 1933 Securities Act, as amended, in force in the United States of America.
Antares Vision also announces that in September, no exercise requests were received. Consequently, the share capital of Antares Vision (equal to Euro 169,419.24, divided into 69,105,497 ordinary shares, 250,000 Special Shares and 1,189,590 Performance Shares, with no nominal value indicated for any category) remained unchanged as well as the warrants outstanding (equal to 2,550,706).
For any further information, please refer to the Warrants Regulation available on the website of Antares Vision www.antaresvision.com - "Investors - Investor Relations - Warrant" section.
The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Regulation.
ABOUT ANTARES VISION GROUP
Listed since April 2019 on the Italian Stock Exchange in the AIM Market, and from 14 May 2021 on Mercato Telematico Azionario (MTA) STAR segment, the Antares Vision Group guarantees protection of products, profit, people and planet through inspection systems for quality control, Track & Trace solutions for anti-counterfeiting and supply chain transparency, smart data management tools for maximized efficiency and digitalization of the entire supply chain, from raw materials to the final consumer. The Antares Vision Group is active in the pharmaceutical market and in Life Science in general (biomedical devices and hospitals), in beverage, food, cosmetic and in consumer-packaged goods. The Group reaches over 60 countries in the World with complete and flexible solutions, hardware, and software, with related services and counts 7 production facilities in Italy (Brescia, Parma, Piacenza, Latina, Padua and Vicenza), 22 foreign subsidiaries (Germany , France , USA , Brazil , United Kingdom , India, Russia , Hong Kong, China, Ireland, Croatia and Serbia), 3 Innovation and Research Centers (Italy) and a worldwide network of more than 40 partners. Thanks to the twenty years of experience in vision technologies of the two founding partners, the Antares Vision Group is the supplier of 10 out of 20 leading pharmaceutical companies in the world, with more than 25,000 inspection systems, that ensure everyday product safety and quality, 6,500 quality controls and more than 3,500 serialization modules on lines installed all over the world. With the aim of continuing and supporting the growth and development strategy, during 2019 participation agreements were finalized with T2 Software, a Brazilian company specialized in smart data management solutions, and Orobix, an Italian company leader in artificial intelligence services, as well as the acquisition of 100% of FT System, leader in control and inspection in the beverage sector. In 2020, Antares Vision acquired 82,83% of Tradeticity, a Croatian company specialized in software management of traceability and serialization processes, 100% of Convel, an Italian company specialized in automated inspection machines for the pharmaceutical industry, the assets of Adents High Tech International, a French company specialized in software for serialization and traceability, 100% of Applied Vision, a global leader in inspection systems for glass and metal containers in food & beverage. In March 2021, Antares Vision acquired 100% of rfXcel Corporation, specialized in software solutions for digitalization and supply chain transparency based in the U.S., and 100% of Pen-Tec and Tecnel, through FT System, increasing specialization in Food & Beverage inspection sector. Further information can be found on the website www.antaresvision.com and on www.antaresvisiongroup.com.
Antares Vision S.p.A. published this content on 04 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 October 2021 17:21:27 UTC.